Valneva SE (VALN) Other Accumulated Expenses (2023 - 2026)

Valneva SE's (VALN) quarterly Other Accumulated Expenses came in at $6.3 million in Q1 2026, up 33.21% year-on-year from $4.8 million in Q1 2025, and down 4.34% quarter-over-quarter from $6.6 million in Q4 2025.

Valneva SE (VALN) Other Accumulated Expenses (2023 - 2026) Analysis & Trends

Valneva SE has disclosed Other Accumulated Expenses across 4 years of filings, most recently posting $6.3 million for Q1 2026.

  • Other Accumulated Expenses for Q1 2026 came in at $6.3 million, up 33.21% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (up 33.21% YoY), and the FY2025 annual result was $6.6 million, up 20.29% from the prior year.
  • Other Accumulated Expenses came in at $6.3 million for Q1 2026 at Valneva SE, down from $6.6 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $10.8 million in Q2 2025 to a low of $636956.4 in Q4 2023.
  • The 4-year median for Other Accumulated Expenses is $6.3 million (2026), against an average of $6.2 million.
  • Across the five-year window, Other Accumulated Expenses surged 764.33% in 2024 and climbed 20.29% in 2025, its largest moves.
  • Valneva SE's Other Accumulated Expenses stood at $636956.4 in 2023, then jumped by 764.33% to $5.5 million in 2024, then gained by 20.29% to $6.6 million in 2025, then dropped by 4.34% to $6.3 million in 2026.
  • The last three Other Accumulated Expenses figures came in at $6.3 million (Q1 2026), $6.6 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.33 Mn
Dec 31, 2025 6.62 Mn
Sep 30, 2025 8.80 Mn
Jun 30, 2025 10.79 Mn
Mar 31, 2025 4.76 Mn
Dec 31, 2024 5.51 Mn
Dec 31, 2023 636,956.43